Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
Clinical trial NCT05215561 · COMPLETED
Trial details
- NCT number
- NCT05215561
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-14
- Primary completion
- 2024-09-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.